Output Biosciences

Output Biosciences develops Biologically-Aware Generative AI models to accelerate drug discovery and understand complex biological systems. Their Large Biological Models can generate breakthrough medicines by processing the extensive, nonlinear, fragmented, and high-dimensional data inherent in biological systems.

Key features:
- Biological Data Modeling: Generative AI models designed to understand and model complex biological data including genomics, proteomics, metabolomics, and other omics data types.
- Drug Candidate Generation: Ability to generate novel drug candidate molecules with optimized properties such as high potency, favorable ADME/PK profiles, and synthetic feasibility.
- Comprehensive Biological Integration: Integration of diverse biological data sources to build comprehensive models of biological systems at molecular, cellular, tissue, and organism scales.
- AI-Enabled Biological Tasks: Leveraging large language models (LLMs) and other generative AI techniques for drug design, target identification, and biological mechanism elucidation.

Use of AI:
Output Biosciences employs generative AI models specifically tailored for biological data. These models are designed to handle the unique challenges of biological information, including its complexity, non-linearity, and high dimensionality.

AI foundation model:
While specific details about their AI architectures are not publicly disclosed, the company claims to be developing novel "Biologically-Aware Generative AI" approaches customized for biological data processing and analysis.

Target users:
- Pharmaceutical companies
- Biotech startups
- Academic researchers in drug discovery and systems biology

How to access:
Output Biosciences is currently focused on internal R&D efforts to develop their generative AI drug discovery platform. The company does not offer a commercial software product at this time.

Company background:
Output Biosciences was founded by repeat entrepreneurs with experience in AI-driven biotech, computational biology, and drug development. The company has secured venture funding to support its research and development efforts.